Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Launched by MANSOURA UNIVERSITY · Oct 21, 2018
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * The patient shall meet all of the following criteria in order to be considered eligible for enrollment:
- • Patient has been diagnosed with NMIBC within 24 months of enrollment
- • At the time of the enrollment visit, the patient is scheduled for a cystoscopy within the next 6 weeks of enrollment
- Exclusion Criteria:
- • Patient has had an excision procedure or BCG treatment within six weeks (42 days) before enrollment.
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansourah, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials